Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
BBDS
MCID: BNT003
MIFTS: 46

Bent Bone Dysplasia Syndrome (BBDS)

Categories: Bone diseases, Ear diseases, Fetal diseases, Genetic diseases, Oral diseases, Rare diseases
Genes Variations Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Bent Bone Dysplasia Syndrome

About this section

MalaCards integrated aliases for Bent Bone Dysplasia Syndrome:

Name: Bent Bone Dysplasia Syndrome 57 20 73 29 13 6 71
Bbds 57 73
Perinatal Lethal Bent Bone Dysplasia 58
Fgfr2-Related Bent Bone Dysplasia 58
Bent Bone Dysplasia -Fgfr2 Type 20
Dysplasia, Bent Bone Syndrome 39

Characteristics:

Orphanet epidemiological data:

58
fgfr2-related bent bone dysplasia
Inheritance: Autosomal dominant; Prevalence: <1/1000000 (Worldwide); Age of onset: Infancy,Neonatal;

OMIM®:

57 (Updated 05-Mar-2021)
Inheritance:
autosomal dominant


HPO:

31
bent bone dysplasia syndrome:
Inheritance autosomal dominant inheritance


Classifications:

MalaCards categories:
Global: Genetic diseases Rare diseases Fetal diseases
Anatomical: Bone diseases Ear diseases Oral diseases
See all MalaCards categories (disease lists)
Orphanet: 58  
Rare bone diseases
Developmental anomalies during embryogenesis


Sources

Summaries for Bent Bone Dysplasia Syndrome

About this section
GARD : 20 Bent bone dysplasia syndrome is an often lethal skeletal disorder characterized by poor mineralization of the skull (calvarium), craniosynostosis, underdeveloped (hypoplastic) pubic bone (pubis) and clavicles, osteopenia, and bent long bones. Unusual facial features include low-set ears, widely spaced eyes (hypertelorism), midface hypoplasia, prematurely erupted fetal teeth, and small chin (micrognathia). This condition is associated with mutations in the FGFR2 gene.

MalaCards based summary : Bent Bone Dysplasia Syndrome, also known as bbds, is related to craniosynostosis and polyhydramnios. An important gene associated with Bent Bone Dysplasia Syndrome is FGFR2 (Fibroblast Growth Factor Receptor 2), and among its related pathways/superpathways are Actin Nucleation by ARP-WASP Complex and Pathways in cancer. The drugs Buprenorphine and Dexamethasone acetate have been mentioned in the context of this disorder. Affiliated tissues include bone, breast and brain, and related phenotypes are osteopenia and gingival overgrowth

UniProtKB/Swiss-Prot : 73 Bent bone dysplasia syndrome: A perinatal lethal skeletal dysplasia characterized by poor mineralization of the calvarium, craniosynostosis, dysmorphic facial features, prenatal teeth, hypoplastic pubis and clavicles, osteopenia, and bent long bones. Dysmorphic facial features included low-set ears, hypertelorism, midface hypoplasia, prematurely erupted fetal teeth, and micrognathia.

More information from OMIM: 614592
Sources

Related Diseases for Bent Bone Dysplasia Syndrome

About this section

Diseases related to Bent Bone Dysplasia Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 16)
# Related Disease Score Top Affiliating Genes
1 craniosynostosis 10.4
2 polyhydramnios 10.2
3 fgfr craniosynostosis syndromes 10.2
4 campomelic dysplasia and related disorders 10.2
5 esophagus adenocarcinoma 9.8 FGFR2 ERBB2
6 adenocarcinoma 9.8 FGFR2 ERBB2
7 endometrial adenocarcinoma 9.8 FGFR2 ERBB2
8 estrogen-receptor positive breast cancer 9.8 FGFR2 ERBB2
9 uterine carcinosarcoma 9.7 FGFR2 ERBB2
10 bile duct adenocarcinoma 9.7 FGFR2 ERBB2
11 intrahepatic cholangiocarcinoma 9.7 FGFR2 ERBB2
12 cholangiocarcinoma 9.7 FGFR2 ERBB2
13 gastric adenocarcinoma 9.7 FGFR2 ERBB2
14 polycystic kidney disease 9.6 FGFR2 ERBB2
15 lung cancer susceptibility 3 9.6 FGFR2 ERBB2
16 squamous cell carcinoma 9.5 FGFR2 ERBB2

Graphical network of the top 20 diseases related to Bent Bone Dysplasia Syndrome:



Diseases related to Bent Bone Dysplasia Syndrome
Sources

Symptoms & Phenotypes for Bent Bone Dysplasia Syndrome

About this section

Human phenotypes related to Bent Bone Dysplasia Syndrome:

58 31 (show all 30)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 osteopenia 58 31 hallmark (90%) Very frequent (99-80%) HP:0000938
2 gingival overgrowth 58 31 hallmark (90%) Very frequent (99-80%) HP:0000212
3 hypertelorism 58 31 hallmark (90%) Very frequent (99-80%) HP:0000316
4 micrognathia 58 31 hallmark (90%) Very frequent (99-80%) HP:0000347
5 low-set ears 58 31 hallmark (90%) Very frequent (99-80%) HP:0000369
6 brachydactyly 58 31 hallmark (90%) Very frequent (99-80%) HP:0001156
7 megalocornea 58 31 hallmark (90%) Very frequent (99-80%) HP:0000485
8 midface retrusion 58 31 hallmark (90%) Very frequent (99-80%) HP:0011800
9 decreased calvarial ossification 58 31 hallmark (90%) Very frequent (99-80%) HP:0005474
10 short clavicles 58 31 hallmark (90%) Very frequent (99-80%) HP:0000894
11 hypoplastic ischia 58 31 hallmark (90%) Very frequent (99-80%) HP:0003175
12 hirsutism 58 31 hallmark (90%) Very frequent (99-80%) HP:0001007
13 bell-shaped thorax 58 31 hallmark (90%) Very frequent (99-80%) HP:0001591
14 natal tooth 58 31 hallmark (90%) Very frequent (99-80%) HP:0000695
15 coronal craniosynostosis 58 31 hallmark (90%) Very frequent (99-80%) HP:0004440
16 congenital stationary night blindness 58 31 hallmark (90%) Very frequent (99-80%) HP:0007642
17 extramedullary hematopoiesis 58 31 hallmark (90%) Very frequent (99-80%) HP:0001978
18 overfolding of the superior helices 58 31 hallmark (90%) Very frequent (99-80%) HP:0004453
19 steep acetabular roof 58 31 hallmark (90%) Very frequent (99-80%) HP:0010455
20 metopic depression 58 31 hallmark (90%) Very frequent (99-80%) HP:0011223
21 incomplete ossification of pubis 58 31 hallmark (90%) Very frequent (99-80%) HP:0030042
22 abnormality of the periosteum 58 31 hallmark (90%) Very frequent (99-80%) HP:0040166
23 clitoral hypertrophy 31 hallmark (90%) HP:0008665
24 hepatosplenomegaly 58 31 occasional (7.5%) Occasional (29-5%) HP:0001433
25 bowing of the legs 58 31 occasional (7.5%) Occasional (29-5%) HP:0002979
26 malar flattening 31 HP:0000272
27 clitoromegaly 58 Very frequent (99-80%)
28 abnormality of the lower limb 58 Occasional (29-5%)
29 abnormality of the outer ear 58 Very frequent (99-80%)
30 abnormally large globe 31 HP:0001090

Symptoms via clinical synopsis from OMIM®:

57 (Updated 05-Mar-2021)
Head And Neck Eyes:
hypertelorism
megalophthalmos

Head And Neck Ears:
low-set ears
overfolded superior helix
deficient auricle

Genitourinary External Genitalia Female:
clitoromegaly

Chest External Features:
bell-shaped thorax

Chest Ribs Sternum Clavicles And Scapulae:
hypoplastic clavicles
decreased mineralization of inferior margin of scapula

Head And Neck Head:
open metopic suture

Abdomen Liver:
hepatosplenomegaly (rare)

Skeletal Pelvis:
narrow acetabular roof
narrowed ischia
decreased mineralization of pubis

Hematology:
hepatosplenomegaly, with extramedullary hematopoiesis (rare)

Head And Neck Face:
micrognathia
midface hypoplasia

Skeletal Hands:
brachydactyly
areas of periosteal reaction
areas of deficient ossification

Skin Nails Hair Hair:
hirsutism

Skeletal Skull:
coronal craniosynostosis
diminished mineralization of the calvarium

Head And Neck Mouth:
gingival hyperplasia

Head And Neck Teeth:
prenatal teeth

Abdomen Spleen:
hepatosplenomegaly (rare)

Skeletal Limbs:
bending of long bones to varying degrees, particularly femora
prominent periosteum

Clinical features from OMIM®:

614592 (Updated 05-Mar-2021)

Sources

Drugs & Therapeutics for Bent Bone Dysplasia Syndrome

About this section

Drugs for Bent Bone Dysplasia Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 23)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Buprenorphine Approved, Illicit, Investigational, Vet_approved Phase 2 52485-79-7 40400 644073
2
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 2 1177-87-3
3
Dexamethasone Approved, Investigational, Vet_approved Phase 2 50-02-2 5743
4
Bortezomib Approved, Investigational Phase 2 179324-69-7 387447 93860
5 Narcotics Phase 2
6 Analgesics, Opioid Phase 2
7 Narcotic Antagonists Phase 2
8 Analgesics Phase 2
9 Detox adjuvant Phase 2
10 Anti-Inflammatory Agents Phase 2
11 Gastrointestinal Agents Phase 2
12 Hormones Phase 2
13 Hormone Antagonists Phase 2
14 Antineoplastic Agents, Hormonal Phase 2
15 glucocorticoids Phase 2
16 Bendamustine Hydrochloride Phase 2
17 Alkylating Agents Phase 2
18 Antiemetics Phase 2
19 Angiogenesis Inhibitors Phase 2
20 Immunosuppressive Agents Phase 2
21 Immunologic Factors Phase 2
22 Anti-Infective Agents Phase 2
23 Anti-Bacterial Agents Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Buprenorphine Detox With Two Types of Treatment. BBD II Completed NCT00000229 Phase 2 Buprenorphine
2 Buprenorphine Detox With Two Types of Treatment. BBD I Completed NCT00000228 Phase 2 Buprenorphine
3 Buprenorphine Detoxification With Two Types of Treatment. BBD IV Completed NCT00000231 Phase 2 Buprenorphine
4 Buprenorphine Detoxification With Two Types of Treatment. BBD III Completed NCT00000230 Phase 2 Buprenorphine
5 Phase II Study for the Evaluation of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy Completed NCT01056276 Phase 2 Bendamustine;Bortezomib;Dexamethasone
6 A Study of Thalidomide, Bendamustine and Dexamethasone (BTD) Versus Bortezomib, Bendamustine and Dexamethasone (BBD) in Patients With Renal Failure Defined as a GFR Below 30 Mls/Min Completed NCT02424851 Phase 2 Bortezomib;Thalidomide;Bendamustine;Dexamethasone
7 Phase II Study of Bendamustine, Bortezomib, and Dexamethasone (BBD) for Newly Diagnosed Patients With Multiple Myeloma Completed NCT02224729 Phase 2 Bendamustine hydrochloride;Bortezomib;Dexamethasone
8 CHILD-BRIGHT READYorNot[TM] Brain-Based Disabilities Trial Recruiting NCT03852550

Search NIH Clinical Center for Bent Bone Dysplasia Syndrome

Sources

Genetic Tests for Bent Bone Dysplasia Syndrome

About this section

Genetic tests related to Bent Bone Dysplasia Syndrome:

# Genetic test Affiliating Genes
1 Bent Bone Dysplasia Syndrome 29 FGFR2
Sources

Anatomical Context for Bent Bone Dysplasia Syndrome

About this section

MalaCards organs/tissues related to Bent Bone Dysplasia Syndrome:

40
Bone, Breast, Brain, Heart
Sources

Publications for Bent Bone Dysplasia Syndrome

About this section

Articles related to Bent Bone Dysplasia Syndrome:

(show all 36)
# Title Authors PMID Year
1
Bent bone dysplasia-FGFR2 type, a distinct skeletal disorder, has deficient canonical FGF signaling. 57 6
22387015 2012
2
Awareness About Sharps Disposal Leads to Significant Improvement in Healthcare Safety: an Audit of Compliance in the National Health Service During the COVID-19 Pandemic. 61
33163860 2020
3
The Role of Resolvin D1 in the Differential Diagnosis of the Cholangiocarcinoma and Benign Biliary Diseases. 61
32390401 2020
4
Fiberoptic Bronchoscopic Balloon Dilatation of Bronchial Stenosis in Children. 61
30829897 2019
5
Nuclear FGFR2 regulates musculoskeletal integration within the developing limb. 61
30620790 2019
6
Single brand, fully-covered, self-expandable metal stent for the treatment of benign biliary disease: when should stents be removed? 61
29856174 2019
7
Factors influencing disability in patients with chronic low back pain attending a tertiary hospital in sub-Saharan Africa. 61
30646894 2019
8
Blood-borne and sexually transmitted infections: a cross-sectional study in a Swiss prison. 61
30373535 2018
9
An efficient biomarker panel for diagnosis of breast cancer using surface-enhanced laser desorption ionization time-of-flight mass spectrometry. 61
29456844 2018
10
FGFR2 mutations in bent bone dysplasia syndrome activate nucleolar stress and perturb cell fate determination. 61
28595297 2017
11
Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control study. 61
28470951 2017
12
Continuous-Flow O-Alkylation of Biobased Derivatives with Dialkyl Carbonates in the Presence of Magnesium-Aluminium Hydrotalcites as Catalyst Precursors. 61
28140521 2017
13
Cyclohexenylboration of Aldehydes and Ketones with the Borabicyclo[3.3.2]decanes (BBDs). 61
26284657 2015
14
Endoscopic treatment of nonstricture-related benign biliary diseases using covered self-expandable metal stents. 61
25521570 2015
15
Positive Association of Fibroadenomatoid Change with HER2-Negative Invasive Breast Cancer: A Co-Occurrence Study. 61
26098961 2015
16
Bent bone dysplasia syndrome reveals nucleolar activity for FGFR2 in ribosomal DNA transcription. 61
24908667 2014
17
(E)-2-boryl 1,3-dienes from the 10-TMS-9-BBDs: highly selective reagents for the asymmetric synthesis of anti-α,β-disubstituted β-allenylamines from the allylboration of aldimines. 61
25003976 2014
18
Molecular dynamics analysis of the interaction between the human BCL6 BTB domain and its SMRT, NcoR and BCOR corepressors: the quest for a consensus dynamic pharmacophore. 61
24793055 2014
19
[Effects of mechanical transplanting of rice with controlled release bulk blending fertilizer on rice yield and soil fertility]. 61
24984497 2014
20
Breast-feeding and benign breast disease. 61
22185539 2012
21
Benign breast lesions in an African population: A 25-year histopathological review of 1864 cases. 61
22529500 2011
22
Optimisation of ultra-performance LC conditions using response surface methodology for rapid separation and quantitative determination of phenolic compounds in Artemisia minor. 61
21140416 2010
23
(E)-2-boryl-1,3-butadiene derivatives of the 10-TMS-9-BBDs: highly selective reagents for the asymmetric synthesis of anti-1,2-disubstituted 3,4-pentadien-1-ols. 61
19580266 2009
24
History of benign breast disease and risk of breast cancer among women in China: a case-control study. 61
18347922 2008
25
Enzymatic characterization of peroxisomal and cytosolic betaine aldehyde dehydrogenases in barley. 61
18429940 2008
26
Learning in and from brain-based devices. 61
18006739 2007
27
[Biliary stent placement for postoperative benign bile duct stenosis: personal experience]. 61
16910355 2006
28
Asymmetric allyl- and crotylboration with the robust, versatile, and recyclable 10-TMS-9-borabicyclo[3.3.2]decanes. 61
15926828 2005
29
Brain-based devices for the study of nervous systems and the development of intelligent machines. 61
15811220 2005
30
Reliability and validity of the brief behavioral distress scale: a measure of children's distress during invasive medical procedures. 61
11700336 2001
31
The ultraflex diamond stent for benign biliary obstruction. 61
10390334 1999
32
Plastic and metal stents for postoperative benign bile duct strictures: the best and the worst. 61
9468417 1998
33
Improved cytosolic free calcium mobilization and superoxide production in bicarbonate-based peritoneal dialysis solution. 61
9175052 1997
34
From sticky stuff to sweet receptors--achievements, limits and novel approaches to bioadhesion. 61
8839687 1996
35
Bicarbonate-based dialysis solution preserves granulocyte functions. 61
7827187 1994
36
A mathematical model for analyzing beat-to-beat difference in the human fetal heart rate during gestation and labor. 61
3346088 1988
Sources

Variations for Bent Bone Dysplasia Syndrome

About this section

ClinVar genetic disease variations for Bent Bone Dysplasia Syndrome:

6 (show all 11)
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 FGFR2 NM_000141.5(FGFR2):c.1172T>G (p.Met391Arg) SNV Pathogenic 29855 rs387906677 10:123274746-123274746 10:121515232-121515232
2 FGFR2 NM_000141.5(FGFR2):c.1141T>G (p.Tyr381Asp) SNV Pathogenic 29856 rs387906678 10:123274777-123274777 10:121515263-121515263
3 FGFR2 NM_000141.5(FGFR2):c.1150G>A (p.Gly384Arg) SNV Pathogenic 478046 rs1554927408 10:123274768-123274768 10:121515254-121515254
4 FGFR2 NM_000141.5(FGFR2):c.1124A>G (p.Tyr375Cys) SNV Pathogenic 13277 rs121913478 10:123274794-123274794 10:121515280-121515280
5 FGFR2 NM_000141.5(FGFR2):c.1025G>A (p.Cys342Tyr) SNV Pathogenic 13263 rs121918487 10:123276892-123276892 10:121517378-121517378
6 FGFR2 NM_000141.5(FGFR2):c.755C>G (p.Ser252Trp) SNV Pathogenic 13272 rs79184941 10:123279677-123279677 10:121520163-121520163
7 FGFR2 NM_022970.3(FGFR2):c.314A>G (p.Tyr105Cys) SNV Pathogenic 449024 rs1434545235 10:123325014-123325014 10:121565500-121565500
8 FGFR2 NM_000141.5(FGFR2):c.1032G>A (p.Ala344=) SNV Pathogenic 13268 rs121918491 10:123276885-123276885 10:121517371-121517371
9 FGFR2 NM_000141.5(FGFR2):c.758C>G (p.Pro253Arg) SNV Pathogenic 13273 rs77543610 10:123279674-123279674 10:121520160-121520160
10 FGFR2 NM_000141.5(FGFR2):c.1013G>A (p.Gly338Glu) SNV Likely pathogenic 374817 rs1057519044 10:123276904-123276904 10:121517390-121517390
11 FGFR2 NM_000141.5(FGFR2):c.989G>A (p.Arg330Gln) SNV Uncertain significance 577711 rs199757302 10:123276928-123276928 10:121517414-121517414

UniProtKB/Swiss-Prot genetic disease variations for Bent Bone Dysplasia Syndrome:

73
# Symbol AA change Variation ID SNP ID
1 FGFR2 p.Tyr381Asp VAR_067977 rs387906678
2 FGFR2 p.Met391Arg VAR_067978 rs387906677

Sources

Expression for Bent Bone Dysplasia Syndrome

About this section
Search GEO for disease gene expression data for Bent Bone Dysplasia Syndrome.
Sources

Pathways for Bent Bone Dysplasia Syndrome

About this section

Pathways related to Bent Bone Dysplasia Syndrome according to GeneCards Suite gene sharing:

(show all 16)
# Super pathways Score Top Affiliating Genes
1
Actin Nucleation by ARP-WASP Complex 63
Show member pathways
 12.38 FGFR2 ERBB2
2
Pathways in cancer 36
12.28 FGFR2 ERBB2
3
MAPK signaling pathway 36 1
12.19 FGFR2 ERBB2
4
Gastric cancer 36
Show member pathways
 12.18 FGFR2 ERBB2
5
Downstream signaling events of B Cell Receptor (BCR) 65
Show member pathways
 12.13 FGFR2 ERBB2
6
Glioma 36
Show member pathways
 12.08 FGFR2 ERBB2
7
ErbB signaling pathway 36 1
Show member pathways
 12.01 FGFR2 ERBB2
8
mTOR signaling pathway (KEGG) 36
Show member pathways
 11.84 FGFR2 ERBB2
9
G-protein signaling RAC1 in cellular process 23
Show member pathways
 11.83 FGFR2 ERBB2
10
Apoptosis Pathway 70
Show member pathways
 11.74 FGFR2 ERBB2
11
Calcium signaling pathway 36
11.64 FGFR2 ERBB2
12
MAPK Signaling: Mitogen Stimulation Pathway 64
Show member pathways
 11.62 FGFR2 ERBB2
13
Tyrosine Kinases / Adaptors 4
11.33 FGFR2 ERBB2
14
G-protein signaling_RhoA regulation pathway 23
11.09 FGFR2 ERBB2
15
Central carbon metabolism in cancer 36
10.8 FGFR2 ERBB2
16
Alzheimers Disease Pathway 63
10.28 FGFR2 ERBB2
Sources

GO Terms for Bent Bone Dysplasia Syndrome

About this section

Cellular components related to Bent Bone Dysplasia Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 receptor complex GO:0043235 8.62 FGFR2 ERBB2

Biological processes related to Bent Bone Dysplasia Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 MAPK cascade GO:0000165 9.48 FGFR2 ERBB2
2 positive regulation of protein kinase B signaling GO:0051897 9.46 FGFR2 ERBB2
3 protein autophosphorylation GO:0046777 9.43 FGFR2 ERBB2
4 peptidyl-tyrosine phosphorylation GO:0018108 9.4 FGFR2 ERBB2
5 transmembrane receptor protein tyrosine kinase signaling pathway GO:0007169 9.37 FGFR2 ERBB2
6 positive regulation of MAPK cascade GO:0043410 9.32 FGFR2 ERBB2
7 wound healing GO:0042060 9.26 FGFR2 ERBB2
8 positive regulation of kinase activity GO:0033674 9.16 FGFR2 ERBB2
9 positive regulation of epithelial cell proliferation GO:0050679 8.96 FGFR2 ERBB2
10 regulation of ERK1 and ERK2 cascade GO:0070372 8.62 FGFR2 ERBB2

Molecular functions related to Bent Bone Dysplasia Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein kinase activity GO:0004672 9.16 FGFR2 ERBB2
2 protein tyrosine kinase activity GO:0004713 8.96 FGFR2 ERBB2
3 transmembrane receptor protein tyrosine kinase activity GO:0004714 8.62 FGFR2 ERBB2
Sources

Sources for Bent Bone Dysplasia Syndrome

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Mar-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....